nach oben

02.04.2024 | Original Contribution

Exercise training decreases lactylation and prevents myocardial ischemia–reperfusion injury by inhibiting YTHDF2

verfasst von: Gui-e Xu, Pujiao Yu, Yuxue Hu, Wensi Wan, Keting Shen, Xinxin Cui, Jiaqi Wang, Tianhui Wang, Caiyue Cui, Emeli Chatterjee, Guoping Li, Dragos Cretoiu, Joost P. G. Sluijter, Jiahong Xu, Lijun Wang, Junjie Xiao

Erschienen in: Basic Research in Cardiology

Einloggen, um Zugang zu erhalten

Abstract

Exercise improves cardiac function and metabolism. Although long-term exercise leads to circulating and micro-environmental metabolic changes, the effect of exercise on protein post-translational lactylation modifications as well as its functional relevance is unclear. Here, we report that lactate can regulate cardiomyocyte changes by improving protein lactylation levels and elevating intracellular N⁶-methyladenosine RNA-binding protein YTHDF2. The intrinsic disorder region of YTHDF2 but not the RNA m⁶A-binding activity is indispensable for its regulatory function in influencing cardiomyocyte cell size changes and oxygen glucose deprivation/re-oxygenation (OGD/R)-stimulated apoptosis via upregulating Ras GTPase-activating protein-binding protein 1 (G3BP1). Downregulation of YTHDF2 is required for exercise-induced physiological cardiac hypertrophy. Moreover, myocardial YTHDF2 inhibition alleviated ischemia/reperfusion-induced acute injury and pathological remodeling. Our results here link lactate and lactylation modifications with RNA m⁶A reader YTHDF2 and highlight the physiological importance of this innovative post-transcriptional intrinsic regulation mechanism of cardiomyocyte responses to exercise. Decreasing lactylation or inhibiting YTHDF2/G3BP1 might represent a promising therapeutic strategy for cardiac diseases.

Nur mit Berechtigung zugänglich

Bei Y, Huang Z, Feng X, Li L, Wei M, Zhu Y, Liu S, Chen C, Yin M, Jiang H, Xiao J (2022) Lymphangiogenesis contributes to exercise-induced physiological cardiac growth. J Sport Health Sci 11:466–478. https://doi.org/10.1016/j.jshs.2022.02.005CrossRefPubMedPubMedCentral

Bei Y, Pan LL, Zhou Q, Zhao C, Xie Y, Wu C, Meng X, Gu H, Xu J, Zhou L, Sluijter JPG, Das S, Agerberth B, Sun J, Xiao J (2019) Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury. BMC Med 17:42. https://doi.org/10.1186/s12916-019-1268-yCrossRefPubMedPubMedCentral

Bei Y, Wang L, Ding R, Che L, Fan Z, Gao W, Liang Q, Lin S, Liu S, Lu X, Shen Y, Wu G, Yang J, Zhang G, Zhao W, Guo L, Xiao J (2021) Animal exercise studies in cardiovascular research: current knowledge and optimal design-A position paper of the Committee on Cardiac Rehabilitation, Chinese Medical Doctors’ Association. J Sport Health Sci 10:660–674. https://doi.org/10.1016/j.jshs.2021.08.002CrossRefPubMedPubMedCentral

Bernardo BC, Ooi JYY, Weeks KL, Patterson NL, McMullen JR (2018) Understanding key mechanisms of exercise-induced cardiac protection to mitigate disease: current knowledge and emerging concepts. Physiol Rev 98:419–475. https://doi.org/10.1152/physrev.00043.2016CrossRefPubMed

Bostrom P, Mann N, Wu J, Quintero PA, Plovie ER, Panakova D, Gupta RK, Xiao C, MacRae CA, Rosenzweig A, Spiegelman BM (2010) C/EBPbeta controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell 143:1072–1083. https://doi.org/10.1016/j.cell.2010.11.036CrossRefPubMedPubMedCentral

Chang K, Marran K, Valentine A, Hannon GJ (2013) Creating an miR30-based shRNA vector. Cold Spring Harb Protoc 2013:631–635. https://doi.org/10.1101/pdb.prot075853CrossRefPubMed

Chen S, Cao X, Zhang J, Wu W, Zhang B, Zhao F (2022) circVAMP3 drives CAPRIN1 phase separation and inhibits hepatocellular carcinoma by suppressing c-Myc translation. Adv Sci (Weinh). https://doi.org/10.1002/advs.202103817CrossRefPubMedPubMedCentral

Chen X, Zhou X, Wang X (2022) m(6)A binding protein YTHDF2 in cancer. Exp Hematol Oncol 11:21. https://doi.org/10.1186/s40164-022-00269-yCrossRefPubMedPubMedCentral

Chow LS, Gerszten RE, Taylor JM, Pedersen BK, van Praag H, Trappe S, Febbraio MA, Galis ZS, Gao Y, Haus JM, Lanza IR, Lavie CJ, Lee CH, Lucia A, Moro C, Pandey A, Robbins JM, Stanford KI, Thackray AE, Villeda S, Watt MJ, Xia A, Zierath JR, Goodpaster BH, Snyder MP (2022) Exerkines in health, resilience and disease. Nat Rev Endocrinol 18:273–289. https://doi.org/10.1038/s41574-022-00641-2CrossRefPubMedPubMedCentral

10.

Dai X, Lv X, Thompson EW, Ostrikov KK (2022) Histone lactylation: epigenetic mark of glycolytic switch. Trends Genet 38:124–127. https://doi.org/10.1016/j.tig.2021.09.009CrossRefPubMed

11.

Deng X, Qing Y, Horne D, Huang H, Chen J (2023) The roles and implications of RNA m(6)A modification in cancer. Nat Rev Clin Oncol 20:507–526. https://doi.org/10.1038/s41571-023-00774-xCrossRefPubMed

12.

Dou X, Huang L, Xiao Y, Liu C, Li Y, Zhang X, Yu L, Zhao R, Yang L, Chen C, Yu X, Gao B, Qi M, Gao Y, Shen B, Sun S, He C, Liu J (2023) METTL14 is a chromatin regulator independent of its RNA N6-methyladenosine methyltransferase activity. Protein Cell 14:683–697. https://doi.org/10.1093/procel/pwad009CrossRefPubMedPubMedCentral

13.

Fan M, Yang K, Wang X, Chen L, Gill PS, Ha T, Liu L, Lewis NH, Williams DL, Li C (2023) Lactate promotes endothelial-to-mesenchymal transition via Snail1 lactylation after myocardial infarction. Sci Adv 9:eadc9465. https://doi.org/10.1126/sciadv.adc9465CrossRefPubMedPubMedCentral

14.

Fang R, Chen X, Zhang S, Shi H, Ye Y, Shi H, Zou Z, Li P, Guo Q, Ma L, He C, Huang S (2021) EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma. Nat Commun 12:177. https://doi.org/10.1038/s41467-020-20379-7CrossRefPubMedPubMedCentral

15.

Flamand MN, Tegowski M, Meyer KD (2023) The proteins of mRNA modification: writers, readers, and erasers. Annu Rev Biochem 92:145–173. https://doi.org/10.1146/annurev-biochem-052521-035330CrossRefPubMedPubMedCentral

16.

Franzago M, Pilenzi L, Di Rado S, Vitacolonna E, Stuppia L (2022) The epigenetic aging, obesity, and lifestyle. Front Cell Dev Biol 10:985274. https://doi.org/10.3389/fcell.2022.985274CrossRefPubMedPubMedCentral

17.

Fu Y, Zhuang X (2020) m(6)A-binding YTHDF proteins promote stress granule formation. Nat Chem Biol 16:955–963. https://doi.org/10.1038/s41589-020-0524-yCrossRefPubMedPubMedCentral

18.

Gaffney DO, Jennings EQ, Anderson CC, Marentette JO, Shi T, Schou Oxvig AM, Streeter MD, Johannsen M, Spiegel DA, Chapman E, Roede JR, Galligan JJ (2020) Non-enzymatic lysine lactoylation of glycolytic enzymes. Cell Chem Biol 27(206–213):e206. https://doi.org/10.1016/j.chembiol.2019.11.005CrossRef

19.

Gao R, Wang L, Bei Y, Wu X, Wang J, Zhou Q, Tao L, Das S, Li X, Xiao J (2021) Long noncoding RNA cardiac physiological hypertrophy-associated regulator induces cardiac physiological hypertrophy and promotes functional recovery after myocardial ischemia-reperfusion injury. Circulation 144:303–317. https://doi.org/10.1161/CIRCULATIONAHA.120.050446CrossRefPubMed

20.

Gatsiou A, Stellos K (2023) RNA modifications in cardiovascular health and disease. Nat Rev Cardiol 20:325–346. https://doi.org/10.1038/s41569-022-00804-8CrossRefPubMed

21.

Ge Y, Jin J, Li J, Ye M, Jin X (2022) The roles of G3BP1 in human diseases (review). Gene 821:146294. https://doi.org/10.1016/j.gene.2022.146294CrossRefPubMed

22.

Gibb AA, Hill BG (2018) Metabolic coordination of physiological and pathological cardiac remodeling. Circ Res 123:107–128. https://doi.org/10.1161/CIRCRESAHA.118.312017CrossRefPubMedPubMedCentral

23.

Gilbert WV, Nachtergaele S (2023) mRNA regulation by RNA modifications. Annu Rev Biochem 92:175–198. https://doi.org/10.1146/annurev-biochem-052521-035949CrossRefPubMed

24.

Glancy B, Kane DA, Kavazis AN, Goodwin ML, Willis WT, Gladden LB (2021) Mitochondrial lactate metabolism: history and implications for exercise and disease. J Physiol 599:863–888. https://doi.org/10.1113/JP278930CrossRefPubMed

25.

Goodwin GW, Taegtmeyer H (2000) Improved energy homeostasis of the heart in the metabolic state of exercise. Am J Physiol Heart Circ Physiol 279:H1490-1501. https://doi.org/10.1152/ajpheart.2000.279.4.H1490CrossRefPubMed

26.

He M, Yang Z, Abdellatif M, Sayed D (2015) GTPase activating protein (Sh3 Domain) binding protein 1 regulates the processing of microRNA-1 during cardiac hypertrophy. PLoS ONE 10:e0145112. https://doi.org/10.1371/journal.pone.0145112CrossRefPubMedPubMedCentral

27.

Hesser CR, Karijolich J, Dominissini D, He C, Glaunsinger BA (2018) N6-methyladenosine modification and the YTHDF2 reader protein play cell type specific roles in lytic viral gene expression during Kaposi’s sarcoma-associated herpesvirus infection. PLoS Pathog 14:e1006995. https://doi.org/10.1371/journal.ppat.1006995CrossRefPubMedPubMedCentral

28.

Heusch G (2020) Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 17:773–789. https://doi.org/10.1038/s41569-020-0403-yCrossRefPubMed

29.

Heusch G (2024) Myocardial ischemia/reperfusion: Translational pathophysiology of ischemic heart disease. Med 5:10–31. https://doi.org/10.1016/j.medj.2023.12.007CrossRefPubMed

30.

Hou G, Zhao X, Li L, Yang Q, Liu X, Huang C, Lu R, Chen R, Wang Y, Jiang B, Yu J (2021) SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs. Nucleic Acids Res 49:2859–2877. https://doi.org/10.1093/nar/gkab065CrossRefPubMedPubMedCentral

31.

Hou J, Zhang H, Liu J, Zhao Z, Wang J, Lu Z, Hu B, Zhou J, Zhao Z, Feng M, Zhang H, Shen B, Huang X, Sun B, Smyth MJ, He C, Xia Q (2019) YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma. Mol Cancer 18:163. https://doi.org/10.1186/s12943-019-1082-3CrossRefPubMedPubMedCentral

32.

Izzo LT, Wellen KE (2019) Histone lactylation links metabolism and gene regulation. Nature 574:492–493. https://doi.org/10.1038/d41586-019-03122-1CrossRefPubMed

33.

Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, Yang C, Chen Y (2021) The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther 6:74. https://doi.org/10.1038/s41392-020-00450-xCrossRefPubMedPubMedCentral

34.

Kanatsu-Shinohara M, Shinohara T (2013) Spermatogonial stem cell self-renewal and development. Annu Rev Cell Dev Biol 29:163–187. https://doi.org/10.1146/annurev-cellbio-101512-122353CrossRefPubMed

35.

Kleinbongard P, Lieder H, Skyschally A, Heusch G (2023) No sex-related differences in infarct size, no-reflow, and protection by ischaemic pre-conditioning in Gottingen minipigs. Cardiovasc Res 119:561–570. https://doi.org/10.1093/cvr/cvac062CrossRefPubMed

36.

Kmietczyk V, Oelschlager J, Gupta P, Varma E, Hartl S, Furkel J, Konstandin M, Marx A, Loewenthal Z, Kamuf-Schenk V, Jurgensen L, Stroh C, Gorska A, Martin-Garrido A, Heineke J, Jakobi T, Frey N, Volkers M (2023) Ythdf2 regulates cardiac remodeling through its mRNA target transcripts. J Mol Cell Cardiol 181:57–66. https://doi.org/10.1016/j.yjmcc.2023.06.001CrossRefPubMed

37.

Koziol MJ, Bradshaw CR, Allen GE, Costa ASH, Frezza C, Gurdon JB (2016) Identification of methylated deoxyadenosines in vertebrates reveals diversity in DNA modifications. Nat Struct Mol Biol 23:24–30. https://doi.org/10.1038/nsmb.3145CrossRefPubMed

38.

Kumari R, Ranjan P, Suleiman ZG, Goswami SK, Li J, Prasad R, Verma SK (2022) mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification. Cardiovasc Res 118:1680–1692. https://doi.org/10.1093/cvr/cvab160CrossRefPubMed

39.

Lee JM, Hammaren HM, Savitski MM, Baek SH (2023) Control of protein stability by post-translational modifications. Nat Commun 14:201. https://doi.org/10.1038/s41467-023-35795-8CrossRefPubMedPubMedCentral

40.

Li F, Zhao D, Wu J, Shi Y (2014) Structure of the YTH domain of human YTHDF2 in complex with an m(6)A mononucleotide reveals an aromatic cage for m(6)A recognition. Cell Res 24:1490–1492. https://doi.org/10.1038/cr.2014.153CrossRefPubMedPubMedCentral

41.

Li H, Trager LE, Liu X, Hastings MH, Xiao C, Guerra J, To S, Li G, Yeri A, Rodosthenous R, Silverman MG, Das S, Ambardekar AV, Bristow MR, Gonzalez-Rosa JM, Rosenzweig A (2022) lncExACT1 and dchs2 regulate physiological and pathological cardiac growth. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.121.056850CrossRefPubMedPubMedCentral

42.

Li L, Krasnykov K, Homolka D, Gos P, Mendel M, Fish RJ, Pandey RR, Pillai RS (2022) The XRN1-regulated RNA helicase activity of YTHDC2 ensures mouse fertility independently of m(6)A recognition. Mol Cell 82(1678–1690):e1612. https://doi.org/10.1016/j.molcel.2022.02.034CrossRef

43.

Lin H, Zhu Y, Zheng C, Hu D, Ma S, Chen L, Wang Q, Chen Z, Xie J, Yan Y, Huang X, Liao W, Kitakaze M, Bin J, Liao Y (2021) Antihypertrophic memory after regression of exercise-induced physiological myocardial hypertrophy is mediated by the long noncoding RNA Mhrt779. Circulation 143:2277–2292. https://doi.org/10.1161/CIRCULATIONAHA.120.047000CrossRefPubMedPubMedCentral

44.

Liu X, Xiao J, Zhu H, Wei X, Platt C, Damilano F, Xiao C, Bezzerides V, Bostrom P, Che L, Zhang C, Spiegelman BM, Rosenzweig A (2015) miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell Metab 21:584–595. https://doi.org/10.1016/j.cmet.2015.02.014CrossRefPubMedPubMedCentral

45.

Markmiller S, Soltanieh S, Server KL, Mak R, Jin W, Fang MY, Luo EC, Krach F, Yang D, Sen A, Fulzele A, Wozniak JM, Gonzalez DJ, Kankel MW, Gao FB, Bennett EJ, Lecuyer E, Yeo GW (2018) Context-dependent and disease-specific diversity in protein interactions within stress granules. Cell 172(590–604):e513. https://doi.org/10.1016/j.cell.2017.12.032CrossRef

46.

McShane E, Selbach M (2022) physiological functions of intracellular protein degradation. Annu Rev Cell Dev Biol 38:241–262. https://doi.org/10.1146/annurev-cellbio-120420-091943CrossRefPubMed

47.

Moreira JBN, Wohlwend M, Wisloff U (2020) Exercise and cardiac health: physiological and molecular insights. Nat Metab 2:829–839. https://doi.org/10.1038/s42255-020-0262-1CrossRefPubMed

48.

Moreno-Yruela C, Zhang D, Wei W, Baek M, Liu W, Gao J, Dankova D, Nielsen AL, Bolding JE, Yang L, Jameson ST, Wong J, Olsen CA, Zhao Y (2022) Class I histone deacetylases (HDAC1–3) are histone lysine delactylases. Sci Adv 8:eabi6696. https://doi.org/10.1126/sciadv.abi6696CrossRefPubMedPubMedCentral

49.

Mu M, Li X, Dong L, Wang J, Cai Q, Hu Y, Wang D, Zhao P, Zhang L, Zhang D, Cheng S, Tan L, Wu F, Shi YG, Xu W, Shi Y, Shen H (2023) METTL14 regulates chromatin bivalent domains in mouse embryonic stem cells. Cell Rep 42:112650. https://doi.org/10.1016/j.celrep.2023.112650CrossRefPubMed

50.

Nakamura M, Sadoshima J (2018) Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol 15:387–407. https://doi.org/10.1038/s41569-018-0007-yCrossRefPubMed

51.

O’Brown ZK, Boulias K, Wang J, Wang SY, O’Brown NM, Hao Z, Shibuya H, Fady PE, Shi Y, He C, Megason SG, Liu T, Greer EL (2019) Sources of artifact in measurements of 6mA and 4mC abundance in eukaryotic genomic DNA. BMC Genom 20:445. https://doi.org/10.1186/s12864-019-5754-6CrossRef

52.

Olivares AO, Baker TA, Sauer RT (2018) Mechanical protein unfolding and degradation. Annu Rev Physiol 80:413–429. https://doi.org/10.1146/annurev-physiol-021317-121303CrossRefPubMed

53.

Paris J, Morgan M, Campos J, Spencer GJ, Shmakova A, Ivanova I, Mapperley C, Lawson H, Wotherspoon DA, Sepulveda C, Vukovic M, Allen L, Sarapuu A, Tavosanis A, Guitart AV, Villacreces A, Much C, Choe J, Azar A, van de Lagemaat LN, Vernimmen D, Nehme A, Mazurier F, Somervaille TCP, Gregory RI, O’Carroll D, Kranc KR (2019) Targeting the RNA m(6)A reader YTHDF2 selectively compromises cancer stem cells in acute myeloid leukemia. Cell Stem Cell 25(137–148):e136. https://doi.org/10.1016/j.stem.2019.03.021CrossRef

54.

Rabinowitz JD, Enerback S (2020) Lactate: the ugly duckling of energy metabolism. Nat Metab 2:566–571. https://doi.org/10.1038/s42255-020-0243-4CrossRefPubMedPubMedCentral

55.

Ratel D, Ravanat JL, Charles MP, Platet N, Breuillaud L, Lunardi J, Berger F, Wion D (2006) Undetectable levels of N6-methyl adenine in mouse DNA: cloning and analysis of PRED28, a gene coding for a putative mammalian DNA adenine methyltransferase. FEBS Lett 580:3179–3184. https://doi.org/10.1016/j.febslet.2006.04.074CrossRefPubMed

56.

Rho H, Terry AR, Chronis C, Hay N (2023) Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis. Cell Metab 35(1406–1423):e1408. https://doi.org/10.1016/j.cmet.2023.06.013CrossRef

57.

Ries RJ, Zaccara S, Klein P, Olarerin-George A, Namkoong S, Pickering BF, Patil DP, Kwak H, Lee JH, Jaffrey SR (2019) m(6)A enhances the phase separation potential of mRNA. Nature 571:424–428. https://doi.org/10.1038/s41586-019-1374-1CrossRefPubMedPubMedCentral

58.

Schiffers S, Ebert C, Rahimoff R, Kosmatchev O, Steinbacher J, Bohne AV, Spada F, Michalakis S, Nickelsen J, Muller M, Carell T (2017) Quantitative LC-MS provides no evidence for m(6) dA or m(4) dC in the genome of mouse embryonic stem cells and tissues. Angew Chem Int Ed Engl 56:11268–11271. https://doi.org/10.1002/anie.201700424CrossRefPubMed

59.

Su R, Dong L, Li Y, Gao M, He PC, Liu W, Wei J, Zhao Z, Gao L, Han L, Deng X, Li C, Prince E, Tan B, Qing Y, Qin X, Shen C, Xue M, Zhou K, Chen Z, Xue J, Li W, Qin H, Wu X, Sun M, Nam Y, Chen CW, Huang W, Horne D, Rosen ST, He C, Chen J (2022) METTL16 exerts an m(6)A-independent function to facilitate translation and tumorigenesis. Nat Cell Biol 24:205–216. https://doi.org/10.1038/s41556-021-00835-2CrossRefPubMedPubMedCentral

60.

Van Treeck B, Parker R (2018) Emerging roles for intermolecular RNA-RNA interactions in RNP assemblies. Cell 174:791–802. https://doi.org/10.1016/j.cell.2018.07.023CrossRefPubMedPubMedCentral

61.

Varner EL, Trefely S, Bartee D, von Krusenstiern E, Izzo L, Bekeova C, O’Connor RS, Seifert EL, Wellen KE, Meier JL, Snyder NW (2020) Quantification of lactoyl-CoA (lactyl-CoA) by liquid chromatography mass spectrometry in mammalian cells and tissues. Open Biol 10:200187. https://doi.org/10.1098/rsob.200187CrossRefPubMedPubMedCentral

62.

Vujic A, Lerchenmuller C, Wu TD, Guillermier C, Rabolli CP, Gonzalez E, Senyo SE, Liu X, Guerquin-Kern JL, Steinhauser ML, Lee RT, Rosenzweig A (2018) Exercise induces new cardiomyocyte generation in the adult mammalian heart. Nat Commun 9:1659. https://doi.org/10.1038/s41467-018-04083-1CrossRefPubMedPubMedCentral

63.

Wang C, Hou X, Guan Q, Zhou H, Zhou L, Liu L, Liu J, Li F, Li W, Liu H (2023) RNA modification in cardiovascular disease: implications for therapeutic interventions. Signal Transduct Target Ther 8:412. https://doi.org/10.1038/s41392-023-01638-7CrossRefPubMedPubMedCentral

64.

Wang H, Maimaitiaili R, Yao J, Xie Y, Qiang S, Hu F, Li X, Shi C, Jia P, Yang H, Wei M, Zhao J, Zhou Z, Xie J, Jiang J, Cai H, Sluijter JPG, Xu Y, Zhang Y, Xiao J (2021) Percutaneous intracoronary delivery of plasma extracellular vesicles protects the myocardium against ischemia-reperfusion injury in canis. Hypertension 78:1541–1554. https://doi.org/10.1161/HYPERTENSIONAHA.121.17574CrossRefPubMed

65.

Wang JY, Lu AQ (2021) The biological function of m6A reader YTHDF2 and its role in human disease. Cancer Cell Int 21:109. https://doi.org/10.1186/s12935-021-01807-0CrossRefPubMedPubMedCentral

66.

Wang K, Li Y, Qiang T, Chen J, Wang X (2021) Role of epigenetic regulation in myocardial ischemia/reperfusion injury. Pharmacol Res 170:105743. https://doi.org/10.1016/j.phrs.2021.105743CrossRefPubMed

67.

Wang L, Feng J, Feng X, Meng D, Zhao X, Wang J, Yu P, Xu GE, Hu M, Wang T, Lehmann HI, Li G, Sluijter JPG, Xiao J (2023) Exercise-induced circular RNA circUtrn is required for cardiac physiological hypertrophy and prevents myocardial ischaemia-reperfusion injury. Cardiovasc Res 119:2638–2652. https://doi.org/10.1093/cvr/cvad161CrossRefPubMed

68.

Wang L, Wang J, Yu P, Feng J, Xu GE, Zhao X, Wang T, Lehmann HI, Li G, Sluijter JPG, Xiao J (2022) METTL14 is required for exercise-induced cardiac hypertrophy and protects against myocardial ischemia-reperfusion injury. Nat Commun 13:6762. https://doi.org/10.1038/s41467-022-34434-yCrossRefPubMedPubMedCentral

69.

Wang N, Wang W, Wang X, Mang G, Chen J, Yan X, Tong Z, Yang Q, Wang M, Chen L, Sun P, Yang Y, Cui J, Yang M, Zhang Y, Wang D, Wu J, Zhang M, Yu B (2022) Histone lactylation boosts reparative gene activation post-myocardial infarction. Circ Res 131:893–908. https://doi.org/10.1161/CIRCRESAHA.122.320488CrossRefPubMed

70.

Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, Fu Y, Parisien M, Dai Q, Jia G, Ren B, Pan T, He C (2014) N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505:117–120. https://doi.org/10.1038/nature12730CrossRefPubMed

71.

Wei X, Huo Y, Pi J, Gao Y, Rao S, He M, Wei Q, Song P, Chen Y, Lu D, Song W, Liang J, Xu L, Wang H, Hong G, Guo Y, Si Y, Xu J, Wang X, Ma Y, Yu S, Zou D, Jin J, Wang F, Yu J (2022) METTL3 preferentially enhances non-m(6)A translation of epigenetic factors and promotes tumourigenesis. Nat Cell Biol 24:1278–1290. https://doi.org/10.1038/s41556-022-00968-yCrossRefPubMed

72.

Wu G, Zhang X, Gao F (2020) The epigenetic landscape of exercise in cardiac health and disease. J Sport Health Sci 10:648–659. https://doi.org/10.1016/j.jshs.2020.12.003CrossRefPubMedPubMedCentral

73.

Wu TP, Wang T, Seetin MG, Lai Y, Zhu S, Lin K, Liu Y, Byrum SD, Mackintosh SG, Zhong M, Tackett A, Wang G, Hon LS, Fang G, Swenberg JA, Xiao AZ (2016) DNA methylation on N(6)-adenine in mammalian embryonic stem cells. Nature 532:329–333. https://doi.org/10.1038/nature17640CrossRefPubMedPubMedCentral

74.

Xavier VJ, Martinou JC (2021) RNA granules in the mitochondria and their organization under mitochondrial stresses. Int J Mol Sci. https://doi.org/10.3390/ijms22179502CrossRefPubMedPubMedCentral

75.

Xiao J, Rosenzweig A (2021) Exercise and cardiovascular protection: Update and future. J Sport Health Sci 10:607–608. https://doi.org/10.1016/j.jshs.2021.11.001CrossRefPubMedPubMedCentral

76.

Xu H, Wang Z, Chen M, Zhao W, Tao T, Ma L, Ni Y, Li W (2021) YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy. Cell Biosci 11:132. https://doi.org/10.1186/s13578-021-00649-7CrossRefPubMedPubMedCentral

77.

Xu P, Hu K, Zhang P, Sun ZG, Zhang N (2022) Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis. Cancer Cell Int 22:13. https://doi.org/10.1186/s12935-021-02368-yCrossRefPubMedPubMedCentral

78.

Yang P, Mathieu C, Kolaitis RM, Zhang P, Messing J, Yurtsever U, Yang Z, Wu J, Li Y, Pan Q, Yu J, Martin EW, Mittag T, Kim HJ, Taylor JP (2020) G3BP1 is a tunable switch that triggers phase separation to assemble stress granules. Cell 181(325–345):e328. https://doi.org/10.1016/j.cell.2020.03.046CrossRef

79.

Yang S, Wei J, Cui YH, Park G, Shah P, Deng Y, Aplin AE, Lu Z, Hwang S, He C, He YY (2019) m(6)A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade. Nat Commun 10:2782. https://doi.org/10.1038/s41467-019-10669-0CrossRefPubMedPubMedCentral

80.

Yang Y, Mbikyo MB, Zhang J, Zhang Y, Zhang N, Li Z (2022) The lncRNA MIAT regulates CPT-1a mediated cardiac hypertrophy through m(6)A RNA methylation reading protein Ythdf2. Cell Death Discov 8:167. https://doi.org/10.1038/s41420-022-00977-8CrossRefPubMedPubMedCentral

81.

Yang Y, Yan Y, Yin J, Tang N, Wang K, Huang L, Hu J, Feng Z, Gao Q, Huang A (2023) O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N(6)-methyladenosine-dependent manner. Signal Transduct Target Ther 8:63. https://doi.org/10.1038/s41392-023-01316-8CrossRefPubMedPubMedCentral

82.

Yang Z, Yan C, Ma J, Peng P, Ren X, Cai S, Shen X, Wu Y, Zhang S, Wang X, Qiu S, Zhou J, Fan J, Huang H, Gao Q (2023) Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nat Metab 5:61–79. https://doi.org/10.1038/s42255-022-00710-wCrossRefPubMed

83.

Yu J, Chai P, Xie M, Ge S, Ruan J, Fan X, Jia R (2021) Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma. Genome Biol 22:85. https://doi.org/10.1186/s13059-021-02308-zCrossRefPubMedPubMedCentral

84.

Yu P, Wang J, Xu GE, Zhao X, Cui X, Feng J, Sun J, Wang T, Spanos M, Lehmann HI, Li G, Xu J, Wang L, Xiao J (2023) RNA m(6)A-regulated circ-ZNF609 suppression ameliorates doxorubicin-induced cardiotoxicity by upregulating FTO. JACC Basic Transl Sci 8:677–698. https://doi.org/10.1016/j.jacbts.2022.12.005CrossRefPubMedPubMedCentral

85.

Zhang B, Jiang H, Dong Z, Sun A, Ge J (2021) The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases. Genes Dis 8:746–758. https://doi.org/10.1016/j.gendis.2020.07.011CrossRefPubMed

86.

Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, Liu W, Kim S, Lee S, Perez-Neut M, Ding J, Czyz D, Hu R, Ye Z, He M, Zheng YG, Shuman HA, Dai L, Ren B, Roeder RG, Becker L, Zhao Y (2019) Metabolic regulation of gene expression by histone lactylation. Nature 574:575–580. https://doi.org/10.1038/s41586-019-1678-1CrossRefPubMedPubMedCentral

87.

Zhong L, Liao D, Zhang M, Zeng C, Li X, Zhang R, Ma H, Kang T (2019) YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma. Cancer Lett 442:252–261. https://doi.org/10.1016/j.canlet.2018.11.006CrossRefPubMed

88.

Zou Z, Sepich-Poore C, Zhou X, Wei J, He C (2023) The mechanism underlying redundant functions of the YTHDF proteins. Genome Biol 24:17. https://doi.org/10.1186/s13059-023-02862-8CrossRefPubMedPubMedCentral

Titel: Exercise training decreases lactylation and prevents myocardial ischemia–reperfusion injury by inhibiting YTHDF2
verfasst von: Gui-e Xu
Pujiao Yu
Yuxue Hu
Wensi Wan
Keting Shen
Xinxin Cui
Jiaqi Wang
Tianhui Wang
Caiyue Cui
Emeli Chatterjee
Guoping Li
Dragos Cretoiu
Joost P. G. Sluijter
Jiahong Xu
Lijun Wang
Junjie Xiao
Publikationsdatum: 02.04.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: Basic Research in Cardiology
Print ISSN: 0300-8428
Elektronische ISSN: 1435-1803
DOI: https://doi.org/10.1007/s00395-024-01044-2

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Exercise training decreases lactylation and prevents myocardial ischemia–reperfusion injury by inhibiting YTHDF2

Abstract

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie